Business Wire

SAMSUNG-ELECTRONICS

Share
Samsung Electronics Expands its ‘Green Chip’ Line-Up

Samsung Electronics Co., Ltd., a world leader in advanced semiconductor technology, today announced that five of its memory products achieved global recognition for successfully reducing its carbon emission, while 20 additional memory products received carbon footprint certification. Samsung’s automotive LED packages also had their carbon footprint verification, a first in the industry for automotive LED packages, further expanding Samsung’s portfolio of eco-conscious ‘green chips’.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211122006067/en/

“It is exciting to see our environmentally sustainable efforts receiving global acknowledgements,” said Seong-dai Jang, Senior Vice President and Head of DS Corporate Sustainability Management Office at Samsung Electronics. “We will continue our path towards a sustainable future with ‘greener’ chips enabled by Samsung’s cutting-edge technology.”

Five memory products achieve the Carbon Trust ‘Reducing CO2’ certification

Five Samsung memory products – HBM2E (8GB), GDDR6 (8Gb), UFS 3.1 (512GB), Portable SSD T7 (1TB), microSD EVO Select (128GB) – recently earned ‘Reducing CO2’ labels from the Carbon Trust. The previous versions of the five products had received the ‘CO2 Measured’ certification from the Carbon Trust last year. The Carbon Trust recently also certified the product carbon footprints of 20 memory products1 by giving them the ‘CO2 Measured’ product carbon footprint label.

The Carbon Trust is an independent and expert partner of organizations that advises businesses on their opportunities in a sustainable, low-carbon world. The Carbon Trust also certifies the environmental footprint of organizations, supply chains and products.

The Reducing CO2 label certifies that a product’s carbon emission has decreased. Samsung was able to cut the carbon emission of the five memory products through enhanced production efficiency. This means that less electricity and raw materials were used per chip. For the Portable SSD T7 (1TB), Samsung used environmentally sustainable paper instead of plastic as packaging material to minimize the carbon footprint of the product.

Samsung estimates that the volume of carbon emissions reduced from the five products, after their release until July 2021, amounts to approximately 680,000 metric tons of CO2, which is equivalent to 11.3 million urban tree seedlings grown for ten years or the greenhouse gas emitted from 149,000 cars driven for one year.

Before a product can be certified for carbon reduction, its current carbon footprint must be validated in order to set the starting line for measuring carbon footprint changes. The CO2 Measured label verifies the current carbon emission of the product with a globally recognized specification (PAS 2050). Thus, the 20 Samsung memory products with the CO2 Measured label has now set the benchmark for future carbon reduction.

“We have certified five of Samsung’s memory chip products with the CO2 Reducing label, and are pleased to bring on board 20 more products with the CO2 Measured label,” said Hugh Jones, Managing Director at the Carbon Trust Advisory. “We hope that Samsung’s efforts could spread out to the entire semiconductor industry, so that the industry can continue its journey towards a more sustainable future.”

Carbon footprint of C-series 3W Automotive LEDs verified by UL

Four C-series 3W Automotive LED packages manufactured by Samsung – Gen3 (third generation) 3W White, Gen3 3W Amber, Gen2 (second generation) 3W White, and Gen2 3W Amber – received verification of their carbon footprint to ISO 14064-3 by UL.

UL, the global safety science leader, provides testing, inspection and certification, advisory and risk management services, decision-making tools, training and business intelligence offerings to help customers based in more than 100 countries solve critical business challenges, achieve sustainability goals, and prepare for future opportunities.

Since Samsung’s C-series 3W Automotive LED packages are energy efficient products that draw less power but produces more light output, they reduce carbon emissions of cars by improving energy efficiency and ensure longer driving range for electric vehicles in a single charge.

“UL congratulates Samsung for pursuing carbon footprint verification for their four C-series 3W Automotive LED packages, which will help automotive manufacturers select products with transparent, verified information about their environmental footprint,” said Doug Lockard, Vice President and General Manager of UL’s Retail and Consumer Products group. “By understanding the carbon impact of products, manufacturers like Samsung can work to reduce those impacts and improve the environmental performance of products over time.”

# # #

About Samsung Electronics Co., Ltd.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, and memory, system LSI, foundry and LED solutions. For the latest news, please visit the Samsung Newsroom at http://news.samsung.com .


1 SODIMM(8GB/16GB), LPDDR5(8GB/12GB/16GB), RDIMM(16GB/32GB), 980 PRO SSD(250GB/500GB/1TB/2TB), HBM2E(16GB), GDDR6(16Gb), UFS 3.1(128GB/256GB), microSD EVO Select(64GB/256GB/512GB), Portable SSD T7(500GB/2TB)

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye